Pancreatic Islet Cell Transplantation: An Update Authors
First Online: 16 October 2012 Received: 24 August 2012 Accepted: 06 October 2012 DOI:
Cite this article as: Hatziavramidis, D.T., Karatzas, T.M. & Chrousos, G.P. Ann Biomed Eng (2013) 41: 469. doi:10.1007/s10439-012-0676-3 Abstract
Transplantation of pancreatic islets, as a therapeutic modality for type 1 diabetes mellitus (T1DM), at this stage of its development, is reserved for patients with severe glycemic variability, progressive diabetic complications, and life threatening hypoglycemia unawareness, regardless of intensive insulin management. It has not succeeded to become the method of choice for treating T1DM because of limited supply and suboptimal yields of procurement and isolation of islets, graft failure, and relatively high requirements, i.e., at least 10,000 functional Islet Equivalents per kg of patient weight, to achieve prolonged insulin independence and glucose stability. Efforts aimed at making islet transplantation a competitive alternative to exogenous insulin injections for treating T1DM have focused on improving the longevity and functionality of islet cells. In order to succeed, these efforts need to be complemented by others to optimize the rate and efficiency of encapsulation.
Keywords Diabetes type 1 Pancreatic cell islet Immunoisolation Encapsulation device Hydrogel Selective withdrawal Hydrodynamic focusing Valveless pump
Associate Editor Stefan Jockenhoevel oversaw the review of this article.
Blyth, M. G., and C. Pozrikidis. Particle encapsulation due to thread breakup in stokes flow.
J. Fluid Mech.
Cohen, I., H. Li, J. L. Hougland,
. Using selective withdrawal to coat microparticles.
Cruise, G. M., O. D. Hegre, D. S. Scharp, and J. A. Hubbell. A sensitivity study of the key parameters in the interfacial photopolymerization of poly(ethylene glycol) diacrylate upon porcine islets.
de Vos, P., B. J. de Haan, J. A. Kamps,
. ζ-Potentials of alginate-PLL capsules: a predictive measure for biocompatibility?
J. Biomed. Mater. Res. A
Golocheikine, A., V. Tiriveedhi, N. Angaswamy,
. Cooperative signaling for angiogenesis and nonvascularization by VEGF and HGF following islet transplantation.
Hatziavramidis, D., and C. Pozrikidis. Hydrodynamic analysis of pancreatic islet micro-encapsulation by selective withdrawal.
Eng. Anal. Bound. Elem.
Hu, H. H., D. D. Joseph, and M. J. Crochet. Direct simulation of fluid particle motions.
Theor. Comput. Fluid Dyn.
Kizilel, S., V. H. Perez-Luna, and F. Teymour. Photopolymerization of poly(ethylene glycol) diacrylate on eosin-functionalized surfaces.
Kroon, E., L. A. Martinson, K. Kadoya,
. Pancreatic endotherm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.
Lakey, J. R., T. Kin, G. L. Warnock,
. Long-term graft function after allogeneic islet transplantation.
Lee, G. B., C. I. Hung, B. J. Ke,
. Hydrodynamic focusing for a micromachined flow cytometer.
J. Fluid Eng. Trans. ASME
Lister, J. R. Selective withdrawal from viscous two-layer system.
J. Fluid Mech.
McCall, M., C. Toso, J. Emamaullee,
. The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice.
Miao, G., J. Mace, M. Kirby,
. In vitro and in vivo improvement of islet survival following treatment with nerve growth factor.
O’Sullivan, E. S., A. Vegas, D. G. Anderson, and G. C. Weir. Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain.
Olsson, A., G. Stemme, and E. Stemme. Diffuser-element design investigation for valve-less pumps.
Sensors Actuators A
Pan, L. S., T. Y. Ng, G. R. Liu,
. Analytical solutions for the dynamic analysis of a valveless micropump.
Sensors Actuators A
Pileggi, A., R. D. Molano, T. Berney,
. Heme Oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation.
Plesner, A. and C. B. Verchere. Advances and challenges in islet transplantation: islet procurement rates and lessons learned from suboptimal islet transplantation.
2011: article ID 979527. doi:
Plesner, A., G. Soukhatcheva, R. G. Korneluk, and C. B. Verchere. XIAP inhibition of β-cell apoptosis reduces the number of islets required to restore euglycemia in a syngeneic islet transplantation model.
Rivas-Carrillo, J. D., A. Soto-Gutierez, N. Navarro-Alvarez,
. Cell-permeable pentapeptide V5 inhibits apoptosis and enhances insulin secretion, allowing experimental single-donor islet transplantation in mice.
Robertson, R. P. Islet transplantation a decade later and strategies for filling a half-full glass.
Ryan, E. A., J. R. T. Lakey, B. W. Paty,
. Successful islet transplantation: continued insulin reserve provides long-term glycemic control.
Schneider, S., P. Feilen, V. Sloty,
. Multilayer capsules: a promising microencapsulation system for transplantation of pancreatic islets.
Scott, W. E., B. P. Weegman, J. Ferrer-Fabrega,
. Pancreas oxygen persufflation increases ATP levels as shown by nuclear magnetic resonance.
Shapiro, A. M. J., J. R. T. Lakey, E. A. Ryan,
. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
N. Engl. J. Med.
Shapiro, A. M. J., C. Ricordi, B. J. Hering,
. International trial of the Edmonton protocol for islet transplantation.
N. Engl. J. Med.
Sharp, D., P. Lacy, C. Ricordi,
et al. Human islet transplantation in patients with type I diabetes. Transplant. Proc. 21:2744–2745, 1989.
Tateishi, K., J. He, O. Taranova,
. Generation of insulin-secreting islet-like clusters from human skin fibroblasts.
J. Biol. Chem.
Uonaga, T., K. Toyoda, T. Okitsu,
. FGF-21 enhances islet engraftment in mouse syngeneic islet transplantation model.
Wyman, J. L., S. Kizilel, R. Skarbek,
. Immunoisolating pancreatic islets by encapsulation with selective withdrawal.
Yamahata, C., C. Vandevyver, F. Lacharme,
. Pumping of mammalian cells with a nozzle-diffuser micropump.
PubMed CrossRef Copyright information
© Biomedical Engineering Society 2012